每经AI快讯，有投资者在投资者互动平台提问：请问贵公司和宇树科技有哪方面的合作以及业务往 来？ 航宇微（300053.SZ）8月1日在投资者互动平台表示，公司暂无上述合作事项。 （文章来源：每日经济新闻） ...

Group 1 - Yabont Chemical signed a 10-year supply strategic agreement with Jiangsu Hengrui Medicine to enhance collaboration in the pharmaceutical supply chain, effective from August 1, 2025 [1] - Wei Hua New Materials plans to acquire controlling interest in Jiangsu Heyutai Chemical to extend its product chain and improve competitiveness, currently in the planning stage [2] - Fujirey received a government subsidy of 2.0074 million yuan, expected to positively impact profits in 2025 [4] Group 2 - Hangzhou Garden won the land use rights for a plot in Yuhang District for 130 million yuan, planning to build a smart ecological design R&D headquarters with a total investment of no more than 450 million yuan [5] - Baotai's clinical trial for BAT5906, a recombinant anti-VEGF monoclonal antibody, received approval for new indications, aiming to accelerate commercialization [6] - Weisheng Information won multiple projects with a total bid amount of 110 million yuan, including significant contracts with Southern Power Grid and State Grid [8] Group 3 - Dong'an Power reported a 27.37% year-on-year increase in engine sales for July, totaling 34,500 units [13] - Hanma Technology's truck sales reached 956 units in July, marking a 42.69% year-on-year increase [14] - Jiangsu Bank's executives received regulatory approval for their positions, effective immediately [15] Group 4 - Chip Origin expects Q2 revenue of 584 million yuan, a 49.90% increase quarter-on-quarter, with significant growth in intellectual property licensing fees [24] - Dream Network Technology plans to establish a high-end equipment industry investment fund with a target fundraising of 2 billion yuan [26] - Hefei Urban Construction and China Real Estate Development won land use rights for a residential plot in Hefei for 980 million yuan [28] Group 5 - Lu Kang Pharmaceutical's subsidiary received a drug registration certificate for a new medication for erectile dysfunction [28] - Lifan Pharmaceutical's Mesalazine enteric-coated tablets received a drug registration certificate for treating ulcerative colitis [29] - Yahu Pharmaceutical's APL-1401 clinical trial for ulcerative colitis showed positive preliminary results [30]

航宇微8月1日公告，公司董事会近日收到副总经理董文岳的书面辞职报告，董文岳因个人原因申请辞去 公司副总经理职务，辞职后不再担任公司任何职务。董文岳的辞职报告自送达董事会之日起生效。 ...

董文岳先生的副总经理职务原定任期为 2023 年 6 月 5 日至 2026 年 6 月 1 日 届满，根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》及《公司章程》的有关规定，董文岳先生的辞职报告自送达董事会之 日起生效。 截至本公告披露日，董文岳先生未持有公司股票，亦不存在应当履行而未履 行的承诺事项，其辞职不会影响公司的正常生产经营。 公司及董事会对董文岳先生在担任公司副总经理期间为公司发展所作出的 贡献表示衷心感谢。 特此公告。 珠海航宇微科技股份有限公司 证券代码：300053 证券简称：航宇微 公告编号：2025-034 珠海航宇微科技股份有限公司 关于副总经理辞职的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 珠海航宇微科技股份有限公司（以下简称"公司"） 董事会于近日收到公司 副总经理董文岳先生的书面辞职报告。董文岳先生因个人原因，申请辞去公司副 总经理职务，辞职后不再担任公司任何职务。 董 事 会 2025 年 8 月 1 日 ...

国浩律师（深圳）事务所 关于 珠海航宇微科技股份有限公司 2025 年第一次临时股东大会 的 法律意见书 致：珠海航宇微科技股份有限公司 国浩律师（深圳）事务所（以下简称"本所"）接受珠海航宇微科技股份有限 公司（以下简称"公司"）委托，指派本所律师（以下简称"本所律师"）出席公司 2025 年第一次临时股东大会（以下简称"本次股东大会"）。本所律师根据《中华 人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国公司法》（以 下简称"《公司法》"）和中国证券监督管理委员会发布的《上市公司股东会规则》 （以下简称"《股东会规则》"）、《上市公司治理准则》（以下简称"《治理准则》" 等法律、法规、部门规章和规范性文件及《珠海航宇微科技股份有限公司章程》 （以下简称"《公司章程》"）、《珠海航宇微科技股份有限公司股东大会议事规 则》（以下简称"《股东大会议事规则》"）的规定，就公司本次股东大会召开的 相关事宜出具法律意见书。 本所同意将本法律意见书作为公司本次股东大会的必备法律文件予以公告， 并依法对本所出具的法律意见承担相应的责任。 本所律师仅对本次股东大会的召集和召开程序、本次股东大会召集人和出席 会 ...

证券代码：300053 证券简称：航宇微 公告编号：2025-032 珠海航宇微科技股份有限公司 2025 年第一次临时股东大会决议公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1．本次股东大会无增加、变更、否决提案的情况。 2．本次股东大会不涉及变更以往股东大会已通过的决议。 3. 本次股东大会以现场投票和网络投票相结合的方式召开，中小投资者 单独计票。 一、会议召开情况 珠海航宇微科技股份有限公司（以下简称"公司"）2025 年第一次临时股东大 会于 2025 年 6 月 28 日以公告形式发出会议通知。本次股东大会采用现场投票和 网络投票相结合的方式举行。 现场会议召开时间为 2025 年 7 月 14 日（星期一）15:00，召开地点为珠海 市唐家东岸白沙路 1 号欧比特科技园研发楼一楼会议室。网络投票日期和时间： 2025 年 7 月 14 日。其中，通过深圳证券交易所交易系统进行网络投票的时间为 2025 年 7 月 14 日上午 9:15-9:25、9:30-11:30，下午 13:00-15:00；通过深圳证券 交易所互联网系统投 ...

证券代码：300053 证券简称：航宇微 公告编号：2025-033 珠海航宇微科技股份有限公司 关于变更公司独立董事的公告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 珠海航宇微科技股份有限公司（以下简称"公司"）独立董事符锦先生因个人 原因申请辞去公司第六届董事会独立董事职务及其在董事会各专门委员会相关 职务，辞职后不再担任公司任何职务。具体内容详见公司于 2025 年 5 月 16 日在 巨潮资讯网（www.cninfo.com.cn）披露的《关于公司独立董事辞职的公告（公告 编号：2025-022）》。截至本公告日，符锦先生未持有公司股份，亦不存在应当 履行而未履行的承诺事项。 特此公告。 珠海航宇微科技股份有限公司 董事会 2025 年 7 月 14 日 附件：崔文浩先生简历 崔文浩先生，生于 1973 年 7 月，中国国籍，无境外永久居留权，中共党员。 毕业于中国人民大学，财政学，经济学学士。曾任职于航天信托投资有限责任公 司、航天科工财务有限责任公司、中国航天科工集团公司、航天科技控股集团股 份有限公司、航天信息股份有限公司、华夏幸福基业股份有限公 ...

Group 1 - Aike Cyber (688719.SH) shareholders Dachen Chuangtong and Dachen Chuanghong reduced their holdings by 2,298,151 shares, accounting for 1.99% of the total share capital, and did not complete the planned reduction [1] - Benchuan Intelligent (300964.SZ) controlling shareholder Dong Xiaojun reduced his holdings by 355,787 shares, accounting for 0.4582% of the total share capital, bringing his shareholding down to 21.64% [1] - Changlian Co., Ltd. (603648.SH) completed its reduction plan by selling 3,624,050 shares, which is 1% of the total share capital [1] Group 2 - Chuan Yi Technology (002866.SZ) controlling shareholder Zou Weimin and his concerted party reduced their holdings, with Zou's shareholding dropping to 48.53% [2] - Daoshi Technology (300409.SZ) controlling shareholder Rong Jihua plans to reduce his holdings by up to 15,416,611 shares, accounting for 1.97% of the total share capital [2] - Electric Alloy (300697.SZ) completed its reduction plan by selling 2,741,390 shares, which is 0.63% of the total share capital [2] Group 3 - Fujirei (688272.SH) shareholders Suzhou Kongkong, Suzhou Zhaorong, and Shanghai Zhaoren reduced their holdings by 1,215,618 shares, 1,463,490 shares, and 44,944 shares, accounting for 1.60%, 1.93%, and 0.06% of the total share capital respectively [3] - Gaoweida (300465.SZ) controlling shareholder Yingtan Yinggao Investment Consulting Co., Ltd. reduced its holdings by 4,261,700 shares, accounting for 0.96% of the total share capital, bringing its shareholding down to 22.00% [3] - Haizheng Materials (688203.SH) shareholder Sinopec Capital plans to reduce its holdings by up to 3,525,600 shares, accounting for 1.74% of the total share capital [3] Group 4 - Hangyu Micro (300053.SZ) shareholder Yan Jun reduced his holdings by 3,930,000 shares, accounting for 0.56% of the total share capital [4] - He Shi Eye Hospital (301103.SZ) shareholder Advanced Manufacturing Industry Investment Fund plans to reduce its holdings by up to 3,106,074 shares, accounting for 2% of the total share capital [4] - He Yuan Gas (002971.SZ) shareholder Baishide Chuangye completed its reduction plan by selling 854,064 shares, which is 0.415% of the total share capital [4] Group 5 - Huaren Health (301408.SZ) shareholder Saifu Investment reduced its holdings by 2,107,696 shares, accounting for 0.53% of the total share capital [5] - Jiangsu Boyun (301003.SZ) shareholder Gong Wei reduced his holdings by 1,558,900 shares, accounting for 1.57% of the total share capital [5] - Jeya Co., Ltd. (301108.SZ) shareholders Mingyuan Fund and its concerted party did not reduce their holdings, and the reduction plan period expired [5] Group 6 - Longxin General (603766.SH) directors plan to reduce their holdings by up to 350,000 shares and 100,000 shares, accounting for 0.0170% and 0.0049% of the total share capital respectively [6] - Ruchuang Micro-Nano (688002.SH) shareholder Li Weicheng plans to reduce his holdings by up to 8,000,000 shares, accounting for 1.75% of the total share capital [6] - Shilan Micro (600460.SH) shareholder Luo Huabing plans to reduce his holdings by up to 500,000 shares, accounting for 0.03005% of the total share capital [6] Group 7 - Tongfu Microelectronics (002156.SZ) shareholder National Integrated Circuit Industry Investment Fund reduced its holdings by 15,175,969 shares, accounting for 1% of the total share capital [7] - Wangzi New Materials (002735.SZ) controlling shareholder Wang Jinjun reduced his holdings by 9,717,874 shares, accounting for 2.54% of the total share capital [7] - Xingye Co., Ltd. (603928.SH) shareholder Shen Genzhen reduced his holdings by 2,620,000 shares, accounting for 1.00% of the total share capital [7] Group 8 - Yikang Co., Ltd. (301085.SZ) controlling shareholder concerted party reduced its holdings by 633,700 shares, accounting for 0.73% of the total share capital [8] Group 9 - Yiming Pharmaceutical (002826.SZ) major shareholder Zhou Zhan reduced his holdings by 3,586,777 shares, accounting for 1.88% of the total share capital [9] - Yiming Pharmaceutical (002826.SZ) director Xi Ke reduced his holdings by 283,862 shares, accounting for 0.15% of the total share capital [9] - Youyan Powder Materials (688456.SH) concerted party reduced its holdings by 1,030,000 shares, accounting for 0.99% of the total share capital [9] Group 10 - Zhongma Transmission (603767.SH) directors plan to reduce their holdings through block trading and centralized bidding [10] - Zhongqi Co., Ltd. (301215.SZ) shareholder Jiangsu Yueda Group did not reduce its holdings, and the reduction plan period expired [10]

Core Viewpoint - The announcement details the shareholding changes of major shareholders in Zhuhai Hangyu Micro Technology Co., Ltd, specifically regarding the reduction of shares held by Mr. Yan Jun and the impact on voting rights [1][2][3]. Summary by Sections Shareholding Changes - Mr. Yan Jun reduced his holdings by 3,930,000 shares from June 25 to June 30, 2025, representing 0.56% of the total share capital [1]. - Due to the expiration of a voting rights delegation agreement, Mr. Yan's voting rights decreased by 12,600,000 shares, or 1.81% of the total share capital [1][3]. Voting Rights Impact - Before the changes, Mr. Yan held 5,010,719.4 shares, accounting for 7.19% of the total share capital. After the changes, he holds 4,617,719.4 shares, or 6.63% [1]. - The total voting rights held by Mr. Yan decreased from 4,480,215.9 shares (6.43%) to 2,827,215.9 shares (4.06%) [1][4]. Compliance with Disclosure Obligations - The share reduction was conducted in accordance with previously disclosed plans, and Mr. Yan has fulfilled his information disclosure obligations as required by regulations [2][3].

Core Viewpoint - The report outlines the equity changes of Zhuhai Hangyu Micro Technology Co., Ltd., specifically detailing the reduction in shareholding and voting rights of the information disclosing obligor, Yan Jun, due to personal financial needs and non-trading transfers related to divorce property division [1][2]. Section Summaries Section 1: Definitions - The report defines key terms such as "information disclosing obligor" referring to Yan Jun and "Zhuhai Hangyu Micro Technology Co., Ltd." as the listed company [3][4]. Section 2: Information Disclosing Obligor Introduction - Yan Jun is identified as the information disclosing obligor, holding the position of Honorary Chairman and Chief Scientist of the company. He does not hold shares in other listed companies exceeding 5% of their issued shares [5]. Section 3: Purpose of Equity Change and Holding Plan - The equity change is primarily due to Yan Jun's personal financial needs and the reduction of shares through non-trading transfers. He plans to reduce his holdings by up to 15,350,000 shares (2.20% of total share capital) within the next twelve months [6][7]. Section 4: Method of Equity Change - Before the change, Yan Jun held 88,683,344 shares (12.73% of total share capital). After the change, he holds 46,177,194 shares (6.63%), with voting rights reduced to 4.06% [8][9]. Section 5: Trading Activity in the Last Six Months - In the six months prior to the report, Yan Jun sold shares through various methods, including a significant sale of 10,300,000 shares via block trading on May 29, 2025, at an average price of 10.88 RMB per share [12][13]. Section 6: Other Significant Matters - No additional significant matters were disclosed that could mislead the report's content or are required by regulatory authorities [14]. Section 7: Documents for Reference - The report includes a list of documents available for reference regarding the equity changes and trading activities [15].